MicrobeWorld App

appsquarebannerad200x200

ASM Fellowships

Fellowship

Microbes After Hours

Watter-Supply-200x200-Banner

Click for more "Microbes After Hours" videos

Join MicrobeWorld

Subscribe via Email

subscribe

Featured Image

Featured Video

Ebola Virus explained

Supporters

ASM House 200X200

Drugmaker-Neglected Bacteria Gives Cubist $2 Billion Market

Cubist Pharmaceuticals Inc. is working to combat a group of bacteria largely neglected by drugmakers with a medicine analysts say may have $2 billion in sales potential.

The drug, CXA-201, last month entered the final stage of tests generally required for U.S. approval and is about a year ahead of rivals under development. It aims at a difficult-to- treat family of bacteria, called gram-negatives, that are developing resistance to existing medicines and spreading among hospital patients, said Arjun Srinivasan, of the U.S. Centers for Disease Control and Prevention.
Click "source for entire article.

Related press release: "Cubist Antibiotic Programs Featured in 49 Presentations at 51st ICAAC" (http://www.marketwatch.com/story/cubist-antibiotic-programs-featured-in-49-presentations-at-51st-icaac-2011-09-15)

 
 

Comments (0)

Collections (0)

 

American Society for Microbiology
2012 1752 N Street, N.W. • Washington, DC 20036-2904 • (202) 737-3600
American Society For Microbiology © 2014   |   Privacy Policy   |   Terms of Use